Suchergebnisse - "Dungan, Kathleen M"

PubPharm (17)

1

Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes

enthalten in: Primary care diabetes | 2020

von Chilton, R. | Dungan, K. | Shubrook, J. | +1

2

REAL-WORLD IMPLICATIONS OF HYBRID CLOSE LOOP (HCL) INSULIN DELIVERY SYSTEM

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2019

von Faulds, E. | Zappe, J. | Dungan, K.

3

Prevalence, predictors, and outcomes of steroid-induced hyperglycemia in hospitalized patients with hematologic malignancies

enthalten in: Endocrine | 2017

von Healy, S. | Nagaraja, H. | Alwan, D. | +1

4

Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital) : a multicentre, prospective, open-label, non-inferiority randomised trial

enthalten in: The lancet. Diabetes & endocrinology | 2017

von Pasquel, F. | Gianchandani, R. | Rubin, D. | +10

CommentIn: Lancet Diabetes Endocrinol. 2017 Feb;5(2):83-85. - PMID 27964838

5

Medication-induced and spontaneous hypoglycemia carry the same risk for hospital mortality in critically ill patients

enthalten in: Journal of critical care | 2016

von Saliba, L. | Cook, C. | Dungan, K. | +2

6

Subcutaneous liraglutide reduces weight and improves metabolic control in obese participants

enthalten in: Evidence-based medicine | 2015

von Soe, K. | Dungan, K.

CommentOn: N Engl J Med. 2015 Jul 2;373(1):11-22. - PMID 26132939

7

Continuous Glucose Monitoring Use in Hospitalized Patients

enthalten in: Diabetes technology & therapeutics | 2015

von Dungan, K.

CommentOn: Diabetes Technol Ther. 2015 Sep;17(9):611-8. - PMID 25927357

8

Monitoring glycemia in diabetes

enthalten in: The Medical clinics of North America | 2015

von Healy, S. | Dungan, K.

9

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6) : a randomised, open-label, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2014

von Dungan, K. | Povedano, S. | Forst, T. | +4

ErratumIn: Lancet. 2014 Oct 11:384(9951):1348

10

Hyperglycemia in the intensive care unit : is insulin the only option?

enthalten in: Critical care (London, England) | 2013

von Dungan, K.

CommentOn: Crit Care. 2013;17(5):R192. - PMID 24018017